Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Kingston Health Sciences Centre
Kingston, Ontario, Canada
- University Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
- National Cancer Centre Singapore
Singapore, Singapore
- National University Hospital Singapore
Singapore, Singapore
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- Mayo Clinic in Rochester
Rochester, Minnesota, United States
- Metro Minnesota Community Oncology Research Consortium
Saint Louis Park, Minnesota, United States
- Park Nicollet Clinic - Saint Louis Park
Saint Louis Park, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- University of Wisconsin Carbone Cancer Center - University Hospital
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Apr 2013
- Primary completion
- 3 Jun 2016
- Completion
- 19 Mar 2027
- Last update posted
- 30 Apr 2026
- Registered enrollment
- 41
- Registry id
- NCT01849263
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.